Skip to main content
Clinical Trials/ITMCTR2000003802
ITMCTR2000003802
Recruiting
Phase 1

A randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markers

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who meet the diagnostic criteria of ckd2\-4 and grade 1\-2 of acute kidney injury;
  • 2\. Patients who meet the TCM syndrome diagnostic criteria of spleen and kidney deficiency and toxin and blood stasis syndrome;
  • 3\. 24h U\-pro \<\= 2\.5g;
  • 4\. Patients aged from 18 to 75 years old;
  • 5\. Patients voluntarily participate in the clinical trial and sign the informed consent.

Exclusion Criteria

  • 1\. Pregnant women or women preparing for pregnancy and lactation;
  • 2\. Patients with severe primary diseases of other organs and in urgent need of immediate treatment, or with consumptive system diseases such as malignant tumor and active tuberculosis;
  • 3\. Patients after renal transplantation;
  • 4\. Patients with mental illness and those who can't cooperate with each other;
  • 5\. Patients who are allergic to treatment drugs;
  • 6\. Patients who are participating in other drug clinical trials or have participated in other clinical trials within 3 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials